Surmodics Showcases Pounce XL Thrombectomy System Breakthrough

Surmodics Introduces the Pounce XL Thrombectomy System

Surmodics, Inc. (NASDAQ: SRDX), based in Eden Prairie, Minnesota, has made significant strides in the medical device arena with the introduction of its Pounce™ XL Thrombectomy System. This innovative system is specially designed for the non-surgical removal of thrombi and emboli from iliac and femoral arteries, which are critical for restoring adequate blood flow.

FDA Clearance and Market Release

The Pounce XL Thrombectomy System received its 510(k) clearance from the U.S. Food and Drug Administration (FDA), a vital step in ensuring its marketplace acceptance. As it stands, the system is in limited market release, and a full commercial launch is anticipated once this phase is complete. This product stands to enhance treatment protocols in vascular surgery, allowing healthcare professionals to perform procedures more effectively.

Clinical Success Stories

Dr. Walter Rizzoni, a vascular surgeon affiliated with the University of Pittsburgh Medical Center (UPMC) Hamot, was among the first to utilize the Pounce XL system. During a recent procedure in Erie, Pennsylvania, he successfully restored blood flow in a thrombosed stent graft, utilizing the device on an 8 mm diameter stent. His positive experience and the performance of the device underline its potential in clinical settings.

Dr. Rizzoni stated, “The Pounce XL Thrombectomy System removed a significant amount of chronic material during our first use. Its performance was right in line with our experience using the original Pounce and Pounce LP Systems.” This feedback not only highlights the effectiveness of the system but also reinforces its positioning in the market as a highly valuable tool for healthcare practitioners.

Overview of the Pounce Thrombectomy Platform

The Pounce Thrombectomy Platform consists of three devices, each uniquely suited for removing organized thrombus or embolus from arteries of varying sizes. Specifically, it includes the Pounce Thrombectomy System for 3.5–6 mm vessels, the Pounce LP (Low-Profile) System for 2–4 mm vessels, and the newly introduced Pounce XL for larger vessels ranging from 5.5–10 mm in diameter.

What sets these systems apart is their fully mechanical operation, enabling swift removal without the use of thrombolytics or large aspirational equipment. This innovation is particularly beneficial for swift interventions that can significantly impact patient recovery and hospital stay duration.

Innovative Design and Functionality

The Pounce XL Thrombectomy System is indeed a cutting-edge solution—characterized by its “grab-and-go” functionality. It features a straightforward design with three main components: a delivery catheter, a basket wire, and a funnel catheter. The design allows for easy deployment and retrieval of clots, simplifying the thrombectomy procedure while minimizing patient discomfort.

The process involves delivering the basket wire to the clot site through the delivery catheter, deploying expandable nitinol baskets that trap the clot for safe removal. This efficient technique promises reduced invasiveness while maintaining effectiveness.

Insights from the PROWL Registry

Among the ongoing assessments of the Pounce Thrombectomy Platform is the PROWL registry, which is focused on the non-surgical treatment of peripheral artery emboli and thrombi. Early data has shown promising results, including a high rate of procedural flow restoration among subjects with symptoms of limb ischemia.

At a recent medical conference, promising results were presented detailing a substantial percentage of patients not requiring additional thromboemboli treatments after using the Pounce systems. These findings could be instrumental in redefining treatment paths for patients suffering from peripheral artery diseases.

About Surmodics, Inc.

Surmodics, Inc. is recognized for its forward-looking initiatives in developing advanced medical technologies. The company specializes in performance coating technologies aimed at enhancing intravascular medical devices, along with a range of diagnostic tools that bolster healthcare solutions. Surmodics remains committed to addressing unmet clinical challenges through innovation and excellence in product development.

Frequently Asked Questions

What is the Pounce XL Thrombectomy System?

The Pounce XL Thrombectomy System is a medical device designed for the non-surgical removal of thrombi and emboli specifically in the iliac and femoral arteries.

What size vessels is the Pounce XL intended for?

The Pounce XL Thrombectomy System is indicated for vessels ranging from 5.5 to 10 mm in diameter.

How does the system work?

The system works by deploying expandable baskets that capture and remove clots without the need for thrombolytics or large equipment.

Who is involved in the clinical use of the device?

Surgeons like Dr. Walter Rizzoni have successfully used the Pounce XL in clinical settings to restore blood flow in patients.

Where is Surmodics, Inc. headquartered?

Surmodics, Inc. is headquartered in Eden Prairie, Minnesota, where it conducts its research and development efforts.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.